The European vaccine development ecosystem has been strengthened over the last 16 years, thanks to the EVI-led TRANSVAC project, an...

We are thrilled to announce TRANSVAC Academy, a programme providing advanced training in specific vaccinology subjects by leading experts.

January 2024 Despite global vaccination programs reaching the brink of poliomyelitis eradication, the disease is still endemic...

July 2023 The Final meeting of the TRANSVAC2 project was held in a hybrid form on 19-20 April 2023 in Brussels. Over 50 attendees...

ISIDORe (Integrated Services for Infectious Disease Outbreak Research) has announced the launch of its preparedness programme calls for...

Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills, know-how and technical...

Dr Stefan Jungbluth, EVI Head of Business Development, represented TRANSVAC in the 'International Conference on Research Infrastructures...

What do firefighters and vaccine development have in common? Check out the Merck Future Talk Podcast episode on '#TRANSVAC and the Future...

The TRANSVAC Annual Meeting successfully took place on 6-7 September in Frankfurt (DE), including sessions on both TRANSVAC2 and...

Collaboration is key to developing vaccines. Merck's article highlights why collaboration in vaccine manufacturing learning is key to...

What are the gaps and needs of vaccine R&D in Europe? TRANSVAC, European vaccine research infrastructure initiative, set out to find...

ISIDORe – “Integrated Services for Infectious Disease Outbreak Research” was officially launched today. The 21M€ EU-funded large-scale...